Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glioblastoma
100%
Antiangiogenic Therapy
100%
Multimodal Imaging
100%
Physiological Changes
100%
Tumor
50%
Positron Emission Tomography/computed Tomography (PET/CT)
50%
Chemotherapy
37%
Tumor Cells
25%
Hypoxia
25%
Antitumor Effect
25%
Blood Supply
25%
Bevacizumab
25%
Radiotherapy
25%
Imaging Techniques
25%
Antiangiogenic Agents
25%
Radiological Response
25%
Patient Condition
25%
Cardiac Magnetic Resonance Imaging (cMRI)
25%
Tumor Microenvironment
12%
Clinical Trials
12%
Clinically Significant
12%
Hippocampus
12%
Blood Vessels
12%
Current Therapies
12%
Primary Brain Tumor
12%
Infiltration
12%
Brain Tumor
12%
Memory Function
12%
Clinical Significance
12%
Therapeutic Implications
12%
Molecular Analysis
12%
Metabolic Changes
12%
Cell Therapy
12%
Perfusion Magnetic Resonance Imaging
12%
Brain Parenchyma
12%
Resistance to Therapy
12%
Overall Survival
12%
Metabolic Activity
12%
Recurring
12%
Standard of Care
12%
Physiological Response
12%
Histological Analysis
12%
Therapeutic Strategies
12%
Vascularized
12%
Tumor Vasculature
12%
Progression-free Survival
12%
Surgical Resection
12%
Metabolic Response
12%
Diffusion Magnetic Resonance Imaging (dMRI)
12%
Molecular Therapy
12%
Molecular Response
12%
Clinical Investigation
12%
Spatial Learning
12%
Magnetic Resonance Spectroscopy
12%
Bevacizumab Therapy
12%
Glucose Consumption
12%
General Patients
12%
Peritumoral Edema
12%
Cell Imaging
12%
Radiological Changes
12%
Glycolytic Activity
12%
Comparisons with a Control
12%
Acidification
12%
Second-line Treatment
12%
Glucose Uptake
12%
Imaging Protocol
12%
Tomographic Analysis
12%
Early Improvement
12%
Accelerated Approval
12%
Complementary Role
12%
Glycolytic Metabolism
12%
Tissue Extracts
12%
Long-term Potentiation
12%
Radiological Findings
12%
Neurocognitive Function
12%
Neuroscience
12%
Physiologic Imaging
12%
Neural Plasticity
12%
Malignant Brain Tumor
12%
Progression Pattern
12%
Historical Control
12%
Term Memory
12%
Metabolomic Analysis
12%
Medicine and Dentistry
Glioblastoma
100%
Antiangiogenic Therapy
100%
Multimodal Imaging
100%
Positron Emission Tomography
50%
Neoplasm
37%
Bevacizumab
37%
Chemotherapy
37%
Hypoxia
25%
Tumor Cell
25%
Magnetic Resonance Imaging
25%
Clinical Study
25%
Intracranial Tumor
25%
Vascularity
25%
Imaging Technique
25%
Diseases
25%
Radiation Therapy
25%
Tumor Microenvironment
12%
Metabolomics
12%
Brain Cancer
12%
Hippocampus
12%
Overall Survival
12%
Parenchyma
12%
Vascular Bundle
12%
Clinical Trial
12%
Cellular Imaging
12%
Tumor Vascularization
12%
Edema
12%
Perfusion Weighted Imaging
12%
Progression Free Survival
12%
Antiinfective Agent
12%
Spatial Learning
12%
Antiangiogenic
12%
Glucose Uptake
12%
Glucose Intake
12%
Angiogenesis Inhibitor
12%
Short Term Memory
12%
Nerve Cell Plasticity
12%
Long-Term Potentiation
12%
Tissue Extract
12%
Diffusion MRI
12%
Radiological Finding
12%
Tumor
12%
Cellular Therapy
12%
Molecular Therapy
12%
Side Effect
12%
NMR Spectroscopy
12%
Cognition
12%
Neuroscience
Positron Emission Tomography
100%
Chemotherapy
75%
Bevacizumab
75%
Intracranial Tumor
75%
Magnetic Resonance Imaging
50%
Imaging Technique
50%
Radiation Therapy
50%
In Vivo
25%
Cognitive Function
25%
Hippocampus
25%
Neuroscience
25%
Angiogenesis Inhibitor
25%
Nuclear Magnetic Resonance Spectroscopy
25%
Neuronal Plasticity
25%
Molecular Therapy
25%
Glucose Transport
25%
Long-Term Potentiation
25%
Short-Term Memory
25%
Metabolic Pathway
25%
Diffusion MRI
25%
Perfusion Magnetic Resonance Imaging
25%
Parenchyma
25%
Side Effect
25%
Glucose
25%
Immunology and Microbiology
Positron Emission Tomography
100%
Bevacizumab
75%
Magnetic Resonance Imaging
50%
Preclinical Study
50%
Tumor Cell
50%
Vascularization
50%
Tissue Extract
25%
Diffusion Weighted Magnetic Resonance Imaging
25%
Perfusion Magnetic Resonance Imaging
25%
Blood Vessels
25%
Long Term Potentiation
25%
Hippocampus
25%
Short Term Memory
25%
Nuclear Magnetic Resonance Spectroscopy
25%
Overall Survival
25%
Tumor Vascularization
25%
Spatial Learning
25%
Glucose Transport
25%
Progression Free Survival
25%
Nerve Cell Plasticity
25%
Angiogenesis Inhibitor
25%
Parenchyma
25%
Cellular Imaging
25%
Dioxygen
25%
Glucose
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic Therapy
100%
Glioblastoma
100%
Neoplasm
71%
Chemotherapy Regimens
42%
Bevacizumab
42%
Antiangiogenic
28%
Clinical Study
28%
Preclinical Study
28%
Hypoxia
28%
Intracranial Tumor
28%
Diseases
28%
Glucose
28%
Cellular Imaging
14%
Clinical Trial
14%
Brain Cancer
14%
Overall Survival
14%
Tumor Vascularization
14%
Antiinfective Agent
14%
Tumor Microenvironment
14%
Progression Free Survival
14%
Angiogenesis Inhibitor
14%
Edema
14%
Tissue Extract
14%
Side Effect
14%
Veterinary Science and Veterinary Medicine
Neoplasm
100%
Vascularity
42%
Intracranial Tumor
42%
Magnetic Resonance Imaging
28%
Diseases
28%
Hippocampus
14%
Metabolic Pathway
14%
Perfusion Magnetic Resonance Imaging
14%
Radiological Finding
14%
Neurology
14%
Diffusion Weighted Magnetic Resonance Imaging
14%
Tumor
14%
Antiinfective Agent
14%
Metabolomics
14%